Showing 761 - 780 results of 1,322 for search '(( 10 i decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (mean decrease)) ))', query time: 0.20s Refine Results
  1. 761

    Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analy... by Hmwe Hmwe, Kyu

    Published 2024
    “…We estimated that the removal of all evaluated diarrhoeal risk factors would reduce global DALYs from 59·0 million (47·2–73·2) to 4·99 million (1·99–10·0) among all ages combined. Globally in 2021, rotavirus was the predominant cause of diarrhoeal deaths across all ages, with a PAF of 15·2% (11·4–20·1), followed by norovirus at 10·6% (2·3–17·0) and Cryptosporidium spp at 10·2% (7·03–14·3). …”
    Get full text
    Get full text
    Get full text
    article
  2. 762
  3. 763

    Repositioning for pressure injury prevention in adults. by Gillespie, Brigid M

    Published 2020
    “…The intervention was reported to be cost-saving compared with standard care (nursing time cost per patient EUR 206.60 versus EUR 253.10, incremental difference EUR -46.50, 95% CI EUR -1.25 to EUR -74.60). …”
    Get full text
    Get full text
  4. 764
  5. 765
  6. 766
  7. 767
  8. 768
  9. 769
  10. 770
  11. 771
  12. 772
  13. 773
  14. 774
  15. 775
  16. 776
  17. 777

    Awareness of disabilities in pharmacy program recruitment material: are we doing enough? by Hussain, Farhat Naz

    Published 2020
    “…INNOVATIONS in pharmacy. 2020;11(3). doi: https://doi.org/10.24926/iip.v11i3.3339.)…”
    Get full text
    Get full text
  18. 778
  19. 779

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…Patient cohorts with excessive polypharmacy (≥9 medications) had the highest probability of survival up to 1.6 years compared to those with lower medication thresholds (≤4); the mortality rate decreased by 18% for patients with excessive polypharmacy [HR=0.82, 95% CI: 0.71 – 0.94]). …”
    Get full text
    Get full text
    Get full text
  20. 780